Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-04

Clinical Trial Update: The Efficacy & Safety of the UAS Immunotherapy Protocol

View source ↗

Summary

The trial has completed evaluating the efficacy and safety of the UAS Immunotherapy Protocol for perennial allergic rhinitis with seasonal variation. The source…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UAS Immunotherapy Protocol

Snippet

Sponsor: United Allergy Services | Conditions: Perennial Allergic Rhinitis With Seasonal Variation | Status: COMPLETED